US FDA approves a weight loss drug for treating ‘serious’ fatty liver disease; here’s what you need to know
Wednesday, 20 August 2025 () The FDA has approved semaglutide for treating MASH, a significant advancement in liver disease management. Semaglutide, previously used for weight loss and diabetes, addresses both weight reduction and liver health, offering a dual benefit. Clinical trials demonstrated that semaglutide led to MASH resolution in 63% of patients without worsening liver scarring, marking a breakthrough for fatty liver disease treatment.
TODAY ON THE ROBERT SCOTT BELL SHOW: Wage and Tax Slavery, 5 Drugs Harm Hearing, FDA Snubs RFK on Vaccine, Fatty Liver Breakthrough, Indium Metallicum, Pesticide Bill Hides Risks, Michael McNamara,..
Wednesday, 20 August 2025 ()
![Wage and Tax Slavery, FDA Snubs RFK on Vaccine, Fatty Liver Breakthrough, Michael McNamara, "From Trauma To Joy - The RSB S [Video]](https://video.newsserve.net/300/v/20250723/1753299729-Wage-and-Tax-Slavery-FDA-Snubs-RFK-on.jpg)
